Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

NHS Health Check to be digitised to ease GP pressure

US court throws out lawsuits alleging Zantac caused cancer

Investigation launched into alleged animal welfare violations at Neuralink

How eligible patient numbers affect price of rare disease drugs in France

Evidence standard drawn up for digital therapeutics

Vargatef

MHRA logo1

Cancer/ News/ News/ News/ Oncology/ Pharma Market Access/ R&D/ UK & Europe

BI drug named Promising Innovative Medicine in mesothelioma

Andrew McConaghie Boehringer Ingelheim, Early Access to Medicines Scheme, mesothelioma, MHRA, Promising Innovative Medicine, UK market access, Vargatef 0 Comment

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for

X

BI drug named Promising Innovative Medicine in mesothelioma

https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

GSK cancer division delivers good news after string of R&D setbacks
Pfizer/BioNTech strike back in Moderna COVID vaccine lawsuit
Novartis' Pluvicto presents survival benefit for castration-resistant prostate cancer
Little Summit Therapeutics spends big bucks to rebuild pipeline
New Nkarta data backs up natural killer approach to cancer treatment

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com